Literature DB >> 33032339

Adenomyosis: Mechanisms and Pathogenesis.

Junyu Zhai1,2,3, Silvia Vannuccini4,5, Felice Petraglia4, Linda C Giudice1.   

Abstract

Adenomyosis is a common disorder of the uterus, and is associated with an enlarged uterus, heavy menstrual bleeding (HMB), pelvic pain, and infertility. It is characterized by endometrial epithelial cells and stromal fibroblasts abnormally found in the myometrium where they elicit hyperplasia and hypertrophy of surrounding smooth muscle cells. While both the mechanistic processes and the pathogenesis of adenomyosis are uncertain, several theories have been put forward addressing how this disease develops. These include intrinsic or induced (1) microtrauma of the endometrial-myometrial interface; (2) enhanced invasion of endometrium into myometrium; (3) metaplasia of stem cells in myometrium; (4) infiltration of endometrial cells in retrograde menstrual effluent into the uterine wall from the serosal side; (5) induction of adenomyotic lesions by aberrant local steroid and pituitary hormones; and (6) abnormal uterine development in response to genetic and epigenetic modifications. Dysmenorrhea, HMB, and infertility are likely results of inflammation, neurogenesis, angiogenesis, and contractile abnormalities in the endometrial and myometrial components. Elucidating mechanisms underlying the pathogenesis of adenomyosis raise possibilities to develop targeted therapies to ameliorate symptoms beyond the current agents that are largely ineffective. Herein, we address these possible etiologies and data that support underlying mechanisms. Thieme. All rights reserved.

Entities:  

Year:  2020        PMID: 33032339      PMCID: PMC7932680          DOI: 10.1055/s-0040-1716687

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  169 in total

Review 1.  Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy.

Authors:  A S Uduwela; M A Perera; L Aiqing; I S Fraser
Journal:  Obstet Gynecol Surv       Date:  2000-06       Impact factor: 2.347

2.  Expression of integrin β3 and osteopontin in the eutopic endometrium of adenomyosis during the implantation window.

Authors:  Yu Xiao; Tinchiu Li; Enlan Xia; Xiuli Yang; Xiao Sun; Yingfang Zhou
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-09-07       Impact factor: 2.435

3.  The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy.

Authors:  G Kunz; D Beil; H Deininger; L Wildt; G Leyendecker
Journal:  Hum Reprod       Date:  1996-03       Impact factor: 6.918

4.  Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells.

Authors:  Kyong Wook Yi; Sung Hoon Kim; Hyo Jin Ihm; Young Sang Oh; Hee Dong Chae; Chung-Hoon Kim; Byung Moon Kang
Journal:  Fertil Steril       Date:  2015-01-27       Impact factor: 7.329

Review 5.  Oxidative stress and peritoneal endometriosis.

Authors:  Anne Van Langendonckt; Françoise Casanas-Roux; Jacques Donnez
Journal:  Fertil Steril       Date:  2002-05       Impact factor: 7.329

6.  Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis.

Authors:  Christopher N Herndon; Lusine Aghajanova; Shaina Balayan; David Erikson; Fatima Barragan; Gabriel Goldfien; Kim Chi Vo; Shannon Hawkins; Linda C Giudice
Journal:  Reprod Sci       Date:  2016-05-27       Impact factor: 3.060

7.  Uterine adenomyosis which developed from hypoplastic uterus in postmenopausal woman with mayer-rokitansky-kuster-hauser syndrome: a case report.

Authors:  Sungwook Chun; Yeon Mee Kim; Yong-Il Ji
Journal:  J Menopausal Med       Date:  2013-12-27

8.  Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis.

Authors:  H Ota; S Igarashi
Journal:  Fertil Steril       Date:  1993-11       Impact factor: 7.329

9.  Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis.

Authors:  Hui Ye; Yazhou He; Jiarong Wang; Tiange Song; Zhu Lan; Yiqi Zhao; Mingrong Xi
Journal:  J Genet       Date:  2016-09       Impact factor: 1.166

10.  Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis.

Authors:  Jichan Nie; Xishi Liu; Sun-Wei Guo
Journal:  Am J Obstet Gynecol       Date:  2010-01-22       Impact factor: 8.661

View more
  13 in total

Review 1.  Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review.

Authors:  Kiran Kumar Rathinam; Justin Jacob Abraham; Heema Preethy S; Shevaani S A; Maitrayee Sen; Melvin George; Priyadharshini A
Journal:  Eur J Clin Pharmacol       Date:  2022-01-17       Impact factor: 2.953

Review 2.  Molecular Targets for Nonhormonal Treatment Based on a Multistep Process of Adenomyosis Development.

Authors:  Hiroshi Kobayashi
Journal:  Reprod Sci       Date:  2022-07-15       Impact factor: 2.924

Review 3.  Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.

Authors:  Ting-Ting Zhao; Li-Li Pang; Lei-Lei Yang; Ruo-Nan Li; Ling-Xiu Fan; Yi Wen
Journal:  Arch Gynecol Obstet       Date:  2022-08-10       Impact factor: 2.493

4.  Perioperative Suppression of Schwann Cell Dedifferentiation Reduces the Risk of Adenomyosis Resulting from Endometrial-Myometrial Interface Disruption in Mice.

Authors:  Xi Wang; Xishi Liu; Sun-Wei Guo
Journal:  Biomedicines       Date:  2022-05-24

5.  Angle of Uterine Flexion and Adenomyosis.

Authors:  Anjeza Xholli; Umberto Scovazzi; Ambrogio Pietro Londero; Giulio Evangelisti; Elena Cavalli; Maria Giulia Schiaffino; Ilaria Vacca; Francesca Oppedisano; Mattia Francesco Ferraro; Giorgio Sirito; Filippo Molinari; Angelo Cagnacci
Journal:  J Clin Med       Date:  2022-06-04       Impact factor: 4.964

6.  Overexpression of Human Estrogen Biosynthetic Enzyme Hydroxysteroid (17beta) Dehydrogenase Type 1 Induces Adenomyosis-like Phenotype in Transgenic Mice.

Authors:  Taija Heinosalo; Kalle T Rytkönen; Niina Saarinen; Päivi Järvensivu; Pauliina Damdimopoulou; Leena Strauss; Satu Orasniemi; Petricia Horshauge; Michael Gabriel; Pasi Koskimies; Claes Ohlsson; Pauliina Kronqvist; Matti Poutanen
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

7.  Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis.

Authors:  Yi-Yi Wang; Hua Duan; Sha Wang; Yong-Jun Quan; Jun-Hua Huang; Zheng-Chen Guo
Journal:  Reprod Biol Endocrinol       Date:  2021-05-14       Impact factor: 5.211

8.  Mode Switch of Ca2 + Oscillation-Mediated Uterine Peristalsis and Associated Embryo Implantation Impairments in Mouse Adenomyosis.

Authors:  Mingzi Qu; Ping Lu; Karl Bellve; Lawrence M Lifshitz; Ronghua ZhuGe
Journal:  Front Physiol       Date:  2021-11-04       Impact factor: 4.755

9.  Establishment of Adenomyosis Organoids as a Preclinical Model to Study Infertility.

Authors:  Elena Juárez-Barber; Emilio Francés-Herrero; Ana Corachán; Carmina Vidal; Juan Giles; Pilar Alamá; Amparo Faus; Antonio Pellicer; Irene Cervelló; Hortensia Ferrero
Journal:  J Pers Med       Date:  2022-02-04

Review 10.  Unveiling the Pathogenesis of Adenomyosis through Animal Models.

Authors:  Xi Wang; Giuseppe Benagiano; Xishi Liu; Sun-Wei Guo
Journal:  J Clin Med       Date:  2022-03-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.